Table 9.
Item | Pre-pandemic I | Pre-pandemic II | During-pandemic | Post-pandemic | Total | Ratio/% | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
case | ratio/% | case | ratio/% | case | ratio/% | case | ratio/% | ||||
Type | OLI | 58 | 70.72 | 118 | 43.7 | 236 | 52.56 | 149 | 49.34 | 561 | 50.86 |
OLI; MESP | 6 | 7.32 | 66 | 24.44 | 56 | 12.47 | 55 | 18.22 | 183 | 16.60 | |
MESP | 7 | 8.54 | 28 | 10.38 | 65 | 14.48 | 34 | 11.26 | 134 | 12.15 | |
OLI; DDI | 1 | 1.22 | 28 | 10.38 | 41 | 9.13 | 38 | 12.58 | 108 | 9.79 | |
DDI | 2 | 2.44 | 12 | 4.44 | 21 | 4.68 | 22 | 7.28 | 57 | 5.17 | |
MESP; DDI | 0 | 0 | 8 | 2.96 | 12 | 2.67 | 3 | 0.99 | 23 | 2.09 | |
OLI; MESP; DDI | 0 | 0 | 9 | 3.33 | 11 | 2.45 | 1 | 0.33 | 21 | 1.9 | |
OLI; UDE | 7 | 8.54 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0.63 | |
UDE | 0 | 0 | 1 | 0.37 | 4 | 0.89 | 0 | 0 | 5 | 0.45 | |
OLI; UDE; DDI | 0 | 0 | 0 | 0 | 2 | 0.45 | 0 | 0 | 2 | 0.18 | |
MESP; UDE | 1 | 1.22 | 0 | 0 | 1 | 0.22 | 0 | 0 | 2 | 0.18 | |
Total | 82 | 100 | 270 | 100 | 449 | 100 | 302 | 100 | 1103 | 100 | |
Number of irrational problems | 1 | 67 | 81.71 | 159 | 58.89 | 326 | 72.60 | 205 | 67.88 | 757 | 68.63 |
2 | 15 | 18.29 | 102 | 37.78 | 110 | 24.50 | 96 | 31.79 | 323 | 29.28 | |
3 | 0 | 0 | 9 | 3.33 | 13 | 2.90 | 1 | 0.33 | 23 | 2.09 | |
Total | 82 | 100 | 270 | 100 | 449 | 100 | 302 | 100 | 1103 | 100 |
OLI, off-label indications.
MESP, medication errors of special population.
DDI, drug-drug interaction.
UDE, usage and dosage errors.